24 results on '"Dunn, Janet A."'
Search Results
2. Treatment of cancer‐associated venous thromboembolism: 12‐month outcomes of the placebo versus rivaroxaban randomization of the SELECT‐D Trial (SELECT‐D: 12m)
3. The QuinteT Recruitment Intervention supported five randomized trials to recruit to target: a mixed-methods evaluation
4. An observational study showed that explaining randomization using gambling-related metaphors and computer-agency descriptions impeded randomized clinical trial recruitment
5. Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer: The OPTIMA Prelim Trial
6. Central pathology review with two-stage quality assurance for pathological response after neoadjuvant chemotherapy in the ARTemis Trial
7. Adjusting for Patient Crossover in Clinical Trials Using External Data: A Case Study of Lenalidomide for Advanced Multiple Myeloma
8. Effects of paraprotein heavy and light chain types and free light chain load on survival in myeloma: an analysis of patients receiving conventional-dose chemotherapy in Medical Research Council UK multiple myeloma trials
9. Quality of Life Data from a Prospective Randomised Trial of Newly Diagnosed Myeloma Patients with Renal Failure: Optimal Trial
10. Optimal - a Study of Bortezomib, Bendamustine and Dexamethasone (BBD) Vs Thalidomide, Bendamustine and Dexamethasone (BTD) in Patients with Renal Failure Defined As an Egfr below 30 Mls/Min
11. Assessment of Anti-Bacterial Antibodies in Multiple Myeloma Patients at Disease Presentation and in Response to Therapy: Implication for Patient Management
12. Diagnostic Pathways of Myeloma Patients Presenting to Hospital Care and Relationship to End Organ Damage: An Analysis from the Teamm (Tackling EArly Morbidity and Mortality in Myeloma) Trial in 977 Patients
13. Tackling Early Morbidity and Mortality in Myeloma (TEAMM): Assessing the Benefit of Antibiotic Prophylaxis and Its Effect on Healthcare Associated Infections in 977 Patients
14. Anticoagulation Therapy in Selected Cancer Patients at Risk of Recurrence of Venous Thromboembolism: Results of the Select-D™ Pilot Trial
15. From Plateau to MRD-Negative CR: Outcomes in the MRC/NCRI Series of Randomised Trials in Newly Diagnosed Patients With Multiple Myeloma From 1980 to 2016
16. The effectes of palliative care on quality of life in heart failure patients
17. Long-Term Survival in Patients Receiving Conventional Therapy for Newly Diagnosed Multiple Myeloma; Results from United Kingdom Medical Research Council Trials 1980–1997.
18. Early Mortality Following Diagnosis of Multiple Myeloma; Analysis of Patients Entered into the UK Medical Research Council Trials 1980–2002.
19. P86 Evaluating the strength of prognostic factors in a series of 1400 patients with myelomatosis
20. P85 Cox regression versus discriminant techniques: Can we predict a high risk group in stage I epithelial ovarian cancer?
21. P93 Establishing the ethics of randomization in breast cancer trials
22. Comparing trials for the treatment of myelomatosis
23. Developing a prognostic index for stomach cancer
24. Prognostic indices: Who needs them?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.